Inflammatory Bowel Disease · Article 134

How Should Acute Severe Ulcerative Colitis Be Managed During the First 72 Hours?

Acute severe UC requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Acute severe UC clinical reference — Related free clinical resource: First Principles of Gastroenterology and Hepatology.

Acute severe UC: practical clinical approach

This page focuses on Acute severe UC with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Acute severe UC

Clinical takeaway: For Acute severe UC, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Acute severe ulcerative colitis (ASUC) is a medical emergency requiring admission, IV corticosteroids, C. difficile testing, pharmacologic venous-thromboembolism prophylaxis, early flexible sigmoidoscopy with biopsies for CMV when appropriate, serial clinical/CRP monitoring and early colorectal-surgical involvement. The 2025 ACG guideline recommends flexible sigmoidoscopy within 72 hours and preferably within 24 hours. By day 3, inadequate steroid response should trigger rescue therapy with infliximab or cyclosporine and surgical consultation rather than simply continuing steroids.

Day 0: stabilize and confirm severity

Assess stool frequency, bleeding, vitals, hemoglobin, CRP, albumin, electrolytes and abdominal examination. Test for C. difficile. Evaluate for toxic megacolon with imaging when indicated.

Start evidence-based inpatient therapy

Give IV methylprednisolone 60 mg/day or equivalent hydrocortisone dosing. Provide pharmacologic DVT prophylaxis unless a clear contraindication exists. Avoid NSAIDs, opioids and anticholinergic drugs.

Scope early, not aggressively

Flexible sigmoidoscopy, not full colonoscopy, should assess severity and obtain biopsies for CMV. Avoid excessive insufflation in severe disease.

Day 3 is a decision point

Monitor stool frequency, rectal bleeding, vitals and serial CRP. If response is inadequate by day 3, move to infliximab or cyclosporine rescue and involve surgery.

Practical clinical algorithm

Admit and confirm ASUC severity.
Test for C. difficile and assess for toxic megacolon.
Begin IV corticosteroids and DVT prophylaxis.
Perform flexible sigmoidoscopy within 72 hours, preferably within 24.
Track stool frequency, bleeding and CRP daily.
At day 3, decide response vs rescue therapy/colectomy pathway.

Common mistakes to avoid

Delaying sigmoidoscopy for several days.
Continuing IV steroids for a week despite nonresponse.
Withholding DVT prophylaxis solely because stool contains blood.
Giving routine broad-spectrum antibiotics without infection.
Using narcotics for abdominal pain.

Trainee takeaway

ASUC management is a timed pathway: diagnose, steroid-treat and stage quickly, then make a rescue-or-surgery decision by day 3.

Frequently asked questions

Should every ASUC patient receive antibiotics?

No. Routine broad-spectrum antibiotics are not recommended without another indication.

Why DVT prophylaxis despite bleeding?

ASUC carries a high thromboembolic risk; pharmacologic prophylaxis is recommended unless contraindicated.

When should surgery be involved?

Early, especially if response is inadequate by day 3 or toxicity is suspected.

References

1. Thomson ABR. Guideline-Based Management in Gastroenterology. CAPstone Academic Publishers; 2015.

2. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

3. Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. ACG Clinical Guideline Update: Ulcerative Colitis in Adults. Am J Gastroenterol. 2025;120:1187-1224.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions